1uk1: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
A novel class of quinazolinone derivatives as potent, poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors has been discovered. Key, to success was application of a rational discovery strategy involving, structure-based design, combinatorial chemistry, and classical SAR for, improvement of potency and bioavailability. The new inhibitors were shown, to bind to the nicotinamide-ribose binding site (NI site) and the, adenosine-ribose binding site (AD site) of NAD+.
A novel class of quinazolinone derivatives as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors has been discovered. Key to success was application of a rational discovery strategy involving structure-based design, combinatorial chemistry, and classical SAR for improvement of potency and bioavailability. The new inhibitors were shown to bind to the nicotinamide-ribose binding site (NI site) and the adenosine-ribose binding site (AD site) of NAD+.


==Disease==
==Disease==
Line 21: Line 21:
[[Category: protein-inhibitor complex]]
[[Category: protein-inhibitor complex]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 17:02:49 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:25:20 2008''